RESMED INC Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Resmed Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
Resmed Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $387M, a 34% increase year-over-year.
Resmed Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $1.42B, a 23.8% increase year-over-year.
Resmed Inc annual Operating Income (Loss) for 2024 was $1.32B, a 16.6% increase from 2023.
Resmed Inc annual Operating Income (Loss) for 2023 was $1.13B, a 13.2% increase from 2022.
Resmed Inc annual Operating Income (Loss) for 2022 was $1B, a 10.7% increase from 2021.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$1.42B	$387M	+$98.3M	+34%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-10-25
Q2 2024	$1.32B	$381M	+$106M	+38.5%	Apr 1, 2024	Jun 30, 2024	10-K	2024-08-09
Q1 2024	$1.21B	$375M	+$73.9M	+24.6%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-04-26
Q4 2023	$1.14B	$275M	-$5.1M	-1.82%	Oct 1, 2023	Dec 31, 2023	10-Q	2024-01-25
Q3 2023	$1.15B	$289M	+$13.3M	+4.81%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-10-25
Q2 2023	$1.13B	$275M	+$19.9M	+7.78%	Apr 1, 2023	Jun 30, 2023	10-K	2024-08-09
Q1 2023	$1.11B	$301M	+$66.4M	+28.3%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-04-26
Q4 2022	$1.05B	$280M	+$31.5M	+12.7%	Oct 1, 2022	Dec 31, 2022	10-Q	2024-01-25
Q3 2022	$1.01B	$276M	+$13.8M	+5.28%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-10-27
Q2 2022	$1B	$255M	+$13.8M	+5.69%	Apr 1, 2022	Jun 30, 2022	10-K	2024-08-09
Q1 2022	$987M	$234M	+$10.8M	+4.85%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-28
Q4 2021	$976M	$249M	+$27M	+12.2%	Oct 1, 2021	Dec 31, 2021	10-Q	2023-01-27
Q3 2021	$949M	$262M	+$45M	+20.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-10-28
Q2 2021	$904M	$242M	+$18.4M	+8.24%	Apr 1, 2021	Jun 30, 2021	10-K	2023-08-11
Q1 2021	$885M	$223M	+$5.93M	+2.73%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-04-29
Q4 2020	$879M	$222M	+$23.9M	+12.1%	Oct 1, 2020	Dec 31, 2020	10-Q	2022-01-28
Q3 2020	$855M	$217M	+$45.8M	+26.8%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-10-29
Q2 2020	$810M	$223M	+$102M	+84.4%	Apr 1, 2020	Jun 30, 2020	10-K	2022-08-12
Q1 2020	$707M	$218M	+$60.5M	+38.6%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-30
Q4 2019	$647M	$198M	+$40.7M	+25.9%	Oct 1, 2019	Dec 31, 2019	10-Q	2021-01-29
Q3 2019	$606M	$171M	+$27M	+18.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-30
Q2 2019	$579M	$121M	-$25.8M	-17.6%	Apr 1, 2019	Jun 30, 2019	10-K	2021-08-17
Q1 2019	$605M	$157M	+$20.6M	+15.1%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-01
Q4 2018	$584M	$157M	+$11.1M	+7.58%	Oct 1, 2018	Dec 31, 2018	10-Q	2020-01-31
Q3 2018	$573M	$144M	+$31.6M	+28.1%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-25
Q2 2018	$542M	$147M	+$19.5M	+15.3%	Apr 1, 2018	Jun 30, 2018	10-K	2020-08-13
Q1 2018	$522M	$136M	+$29M	+27%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-03
Q4 2017	$493M	$146M	+$49.1M	+50.7%	Oct 1, 2017	Dec 31, 2017	10-Q	2019-02-01
Q3 2017	$444M	$113M	+$18.4M	+19.6%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-26
Q2 2017	$426M	$127M	+$8.72M	+7.35%	Apr 1, 2017	Jun 30, 2017	10-K	2019-08-08
Q1 2017	$417M	$107M	+$3.09M	+2.96%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-04-27
Q4 2016	$414M	$96.9M	-$11.1M	-10.3%	Oct 1, 2016	Dec 31, 2016	10-Q	2018-01-24
Q3 2016	$425M	$94.1M	-$3.88M	-3.96%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-27
Q2 2016	$429M	$119M	+$19.1M	+19.2%	Apr 1, 2016	Jun 30, 2016	10-K	2018-08-17
Q1 2016	$410M	$104M	-$1.56M	-1.47%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-04-28
Q4 2015	$411M	$108M	-$1.17M	-1.07%	Oct 1, 2015	Dec 31, 2015	10-Q	2017-01-25
Q3 2015	$413M	$98M	+$3.35M	+3.54%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-10-28
Q2 2015	$409M	$99.5M	+$1.06M	+1.08%	Apr 1, 2015	Jun 30, 2015	10-K	2017-08-04
Q1 2015	$408M	$106M	+$1.17M	+1.12%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-04-29
Q4 2014	$407M	$109M	+$4.13M	+3.93%	Oct 1, 2014	Dec 31, 2014	10-Q	2016-01-28
Q3 2014	$403M	$94.7M	-$2.21M	-2.28%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-10-27
Q2 2014	$405M	$98.5M	+$12.3M	+14.3%	Apr 1, 2014	Jun 30, 2014	10-K	2016-08-05
Q1 2014	$393M	$105M	+$8.6M	+8.95%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-04-29
Q4 2013	$384M	$105M	+$13M	+14.1%	Oct 1, 2013	Dec 31, 2013	10-Q	2015-01-30
Q3 2013	$371M	$96.9M	+$16.4M	+20.4%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-10-31
Q2 2013	$355M	$86.2M	-$3.57M	-3.97%	Apr 1, 2013	Jun 30, 2013	10-K	2015-08-07
Q1 2013	$358M	$96.1M	+$19.6M	+25.5%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-01
Q4 2012	$339M	$92.1M	+$24.8M	+36.9%	Oct 1, 2012	Dec 31, 2012	10-Q	2014-01-29
Q3 2012	$314M	$80.5M	+$19.6M	+32.2%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-10-30
Q2 2012	$294M	$89.7M	+$23M	+34.5%	Apr 1, 2012	Jun 30, 2012	10-K	2014-08-08
Q1 2012	$271M	$76.5M	+$12.6M	+19.7%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-01
Q4 2011	$259M	$67.3M	-$2.62M	-3.75%	Oct 1, 2011	Dec 31, 2011	10-Q	2013-01-31
Q3 2011	$261M	$60.9M	-$5.52M	-8.31%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-10-31
Q2 2011	$267M	$66.7M			Apr 1, 2011	Jun 30, 2011	10-K	2013-08-13
Q1 2011		$64M	+$2.78M	+4.55%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-01
Q4 2010		$69.9M			Oct 1, 2010	Dec 31, 2010	10-Q	2012-02-02
Q3 2010		$66.4M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-03
Q1 2010		$61.2M			Jan 1, 2010	Mar 31, 2010	10-Q	2011-05-03

* An asterisk sign (*) next to the value indicates that the value is likely invalid.